Td Waterhouse Canada Inc. Seagen Inc. Transaction History

Td Waterhouse Canada Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Nov 13, 2023	SELL	$187.64 - $206.25 $6,942 - $7,631	-37 Closed	0 $0
Q1 2023 Nov 13, 2023	BUY	$127.59 - $203.08 $4,720 - $7,513	37 New	37 $7.47 Million
Q4 2022 Nov 13, 2023	SELL	$117.37 - $139.17 $2,464 - $2,922	-21 Closed	0 $0
Q2 2022 Nov 13, 2023	BUY	$108.81 - $179.33 $1,414 - $2,331	13 Added 162.5%	21 $4.46 Million
Q1 2022 Nov 13, 2023	SELL	$119.61 - $157.85 $837 - $1,104	-7 Reduced 46.67%	8 $1.19 Million
Q4 2021 Nov 13, 2023	BUY	$142.57 - $190.86 $2,138 - $2,862	15 New	15 $2.58 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.